Pfizer said in March to launch the Omikon vaccine

(New York Composite Electric) American Pharmaceutical Pfizer pointed out on Monday that the company is expected to launch a vaccine for coronary virus Omircong in March this year.

President President Aberle interview with the National Broadcasting Corporation Business Channel (CNBC) and said that in response to Omikon's mutant strainBiontech is developing a vaccine specifically for Omikon, as well as a vaccine that contains old vessels, but can cope with Omikon's vaccine.

He pointed out that Omircor's poisonous strains have led to many people who have vaccinated vaccines to break through infection cases, causing surge in new cases, and governments of various countries are facing huge epidemic prevention.The Mikon vaccine will help prevent breakthrough infections.

But he said, it is unclear whether it really needs a vaccine specially targeted at Omikon, and how to use this vaccine, because the existing need to be injected twice and once a reinforcement agent, which must be injected twice and once a reinforcement agent.Crown disease vaccines can be provided with sufficient protection to avoid the severe illness caused by Omikon.

Aberle revealed at the annual medical care conference of JP Morgan Chase that Pfizer could first obtain the authorization of the U.S. regulatory authorities in March and launching a new vaccine.He also said that Pfizer's vaccine was sufficient, and it was absolutely not a problem to immediately convert the production of new Omikon vaccines.

He believes that the crown vaccine may eventually become a vaccine that most people need to vaccinate each year, and some high -risk groups may need to be vaccinated more times.

Modner launched the autumn for Omikon vaccine additional agent

another vaccine producer Modna is developing a targetingOmikon's vaccine additional agent is expected to be launched this fall.

Modner CEO BanBC told CNBC: "We are discussing with public health leaders around the world to determine how to be the best strategy for (the vaccine enhanced agent) ... weMust be careful and try to lead the virus as much as possible. "